Available online 24 May 2016
Review Article
- Open Access funded by Sociedade Brasileira de Farmacognosia
- Under a Creative Commons license
Abstract
Piper marginatum
Jacq., Piperaceae, is a widely distributed Neotropical species abundant
in the Caribbean, exhibiting a characteristic winged petiole and a
heart-shaped leaf, its two vegetative landmarks for rapid
identification. The species has been employed by traditional indigenous
cultures for its reputed medicinal properties. The plant is most
frequently employed by local healers in Central America, the Antilles
and South America, for alleviating gastrointestinal ailments,
administered as a decoction or infusion for its tonic, diuretic and
carminative effects. These beneficial properties may be attributed to
the presence of various phytochemicals within P. marginatum,
with most of the studies focusing on the essential oil of the plant.
Monoterpenoids, sesquiterpenoids and phenylpropanoids of a varied
chemical structure have been identified in the essential oil, while
phenylalkanoids, aristolactams, amides and flavonoids have been purified
by chromatographic techniques from the extracts. The biological and
pharmacological examination of P. marginatum showed that the
plant may be a valuable source of mosquitocidal, antifungal, antitumoral
and hemostatic agents. Future bioguided research may yield biologically
relevant molecules useful in medicine or agriculture.
Keywords
- Piper marginatum Jacq.;
- Piperaceae;
- Folk medicine;
- Phytochemistry;
- Pharmacology;
- Biological applications
Introduction
The species Piper marginatum
Jacq., Piperaceae, was first described in 1781 by Dutch botanist
Nikolaus Joseph von Jacquin. The species had been collected during
excursions to Central and South America, and the morphological
characters were recorded as heart-shaped, acuminated, multi-veined and
reticulated leaves, with a marginal, grooved and winged petiole, and
solitary flowers ( Jacquin, 1786).
The Swiss botanist Anne Casimir Pyrame de Candolle was the first to
observe small morphological differences between different collections of
P. marginatum, and recognized three subspecies: P. marginatum Jacq, P. marginatum var. anisatum (Kunth) C.DC. and P. marginatum var. catalpifolium (Kunth) C.DC. ( Candolle, 1902).
In the comprehensive work “The Piperaceae of Northern South America”,
William Trelease and Truman G. Yuncker, differentiated the subspecies
based on the puberulent (var. anisatum) or pillose (var. catalpifolium) nature of the nerves on the upper surface of the leaves ( Trelease and Yuncker, 1950).
However the difficulty to characterize specimens at the subgenus level
given its extensive homoplasy (the development of similar characters by
parallel or convergent evolution) was recognized by Ricardo Callejas (Callejas, 1986), and thus the modern classifications consider the subspecies as synonyms of P. marginatum Jacq. ( Andrade et al., 2008). In this work, the sensu lato of P. marginatum was considered, following the criteria of the Missouri Botanical Garden ( Tropicos.org, 2015), which collates under P. marginatum several species and subspecies, including Piper san-joseanum C. DC., Piper patulum Bertol., Piper uncatum Trel., Piper quiriguanum Trel., among others.
The phylogenetic analysis of the genus Piper
using the sequence alignment of the internal transcribed spacer (ITS)
of the 18S-26S nuclear ribosomal DNA and the chloroplast intron region psbJ-petA, indicated that the species P. marginatum is closely related to P. multiplinervium and P. schwakei, and together these three species build the P. marginatum complex ( Jaramillo et al., 2008). Moreover the Pothomorphe group species (which includes P. auritum, P. peltatum and P. umbellatum) showed to be phylogenetically related to the P. marginatum complex.
The species P. marginatum
has been widely recognized for its medicinal purposes within a number
of indigenous cultures located in the Caribbean and Amazon regions, from
Central America and the Antilles to Brazil ( de Núñez and Johnson, 1943, Braga, 1960, D’Angelo et al., 1997 and Di Stasi and Hiruma-Lima, 2002). In addition the dried leaves have been used as a natural sweetener ( Hussain et al., 1990 and Surana et al., 2006). Its major secondary metabolites are terpenoids and phenylalkanoids (Andrade et al., 2008). In addition a number of biological and pharmacological published data (Sequeda-Castañeda et al., 2015)
seems to support its use in traditional medicine. This review covers
the ethnomedicinal, phytochemical and biological literature published on
P. marginatum with the aim to identify the research voids for
future investigation and critically assess the potential application of
the species in medicine and agriculture.
Folk medicine and traditional uses
The indigenous communities in Central America, the Antilles and South America repeatedly reported to use P. marginatum
for treating a varied array of diseases and ailments. Gastrointestinal
problems are the most common therapeutic use in the traditional
medicine, spanning different locations and cultures ( Fig. 1, Box 1). The plant is recurrently employed either as a decoction or infusion for its tonic, diuretic and carminative effects ( Foungbe et al., 1976, Johnson, 1998, Di Stasi and Hiruma-Lima, 2002 and de Albuquerque et al., 2007). It is also used to treat gallbladder, liver, stomach, spleen, urinary and gastrointestinal ailments ( van den Berg, 1982, Pereira et al., 2011 and Yukes and Balick, 2011), but also dysentery (de Núñez and Johnson, 1943).
In Central America, the species is known as “Aniseto” and it is
employed as an infusion for treating flatulence disorders, in a similar
way to star anise.
- Box 1. Traditional medicine applications of Piper marginatum by local communities.
Location Organ of the plant Medicinal properties, or afflictions treated Mode of application References Amazon region Roots Carminative, diuretic, tonic, useful against toothache and cobra venom Baths Di Stasi and Hiruma-Lima (2002) Roots To alleviate pain and itching of insect bites Cataplasm Fruits and leaves Stimulant nd Stem, leaves Against itching from ant bites Cataplasm Elisabetsky and Gely (1987) nd As antispasmodic and against liver and gallbladder diseases Decoction van den Berg (1982) Brazil Leaves Rheumatism, bleeding skin wounds, toothache and tumors Decoction Corrêa and Pena (1984), D’Angelo et al. (1997) Leaves To reduce swellings Rubbed with fat as cataplasm, poultice Branch and Silva (1983), Duke and Vasquez (1994) Roots To alleviate hitching caused by insect bites, and also as a teeth pain reliever Maceration Pereira et al. (2011) Leaves and fruits As antispasmodic, to treat cough, and affections of the spleen, liver and intestinal problems Used topically Pereira et al. (2011) Stem, leaves, roots Against high blood pressure, asthma, erysipelas, problems with urinary system and as a diuretic nd de Albuquerque et al. (2007) nd To treat hemorrhoids Infusion Rodrigues and Andrade (2014) nd Hemostatic, snake-bite medicine nd Braga (1960), D’Angelo et al. (1997) Colombia Leaves, stem For protecting teeth against cavities Chewed Duke and Vasquez (1994), García (1974) Leaves Analgesic Infusion and cataplasm Giraldo Tafur (1996) Roots Used against malaria and as stimulant Juice García (1974) Entire plant To reduce fevers Decoction García (1974) Costa Rica Leaves To treat headaches Decoction Hazlett (1986) Cuba nd Antiseptic, astringent, antihemorrhagic and hemostatic nd Sánchez et al. (2011) Dominican Republic Leaves Indigestion and flatulence disorders but also against stomach pain Infusion Yukes and Balick (2011) French Guiana Leaves Used in combination with Quassia amara to treat malaria Decoction Vigneron et al. (2005) Leaves To treat cutaneous eruptions and insect bites Decoction Foungbe et al. (1976) Roots Diuretic and sudorific Infusion Foungbe et al. (1976) nd Used to treat skin rashes nd D’Angelo et al. (1997), Morton (1977) Panama nd Carminative, diuretic, emmenagogue, hemostatic nd Johnson (1998) nd Reduce fever and lung secretions nd D’Angelo et al. (1997), Morton (1977) Puerto Rico Leaves Hemostatic Cataplasm de Núñez and Johnson (1943) Leaves As treatment to dysentery Infusion de Núñez and Johnson (1943) nd Reduces menstruation flow nd Morton (1977) Suriname Leaves To cleanse the vagina, cleanse the uterus, disguise bad smell, enhance sexual pleasure amongst other applications Steam bath van Andel et al. (2008) Trinidad and Tobago nd To help parturition Infusion or decoction drank Lans and Georges (2011) - nd refers to no data.
Pain relief is the second most frequent use of P. marginatum in the traditional medicine ( Fig. 1, Box 1). The plant is used to relieve toothache, headaches and pain caused by itching, and as a general analgesic ( Hazlett, 1986, Giraldo Tafur, 1996, Di Stasi and Hiruma-Lima, 2002 and Pereira et al., 2011).
The plant is employed topically as a cataplasm to alleviate the pain of
the limbs or abdomen, or as a decoction or infusion for teeth, head and
stomach aches ( García, 1974, Giraldo Tafur, 1996 and Yukes and Balick, 2011).
The species P. marginatum is also commonly used as a hemostatic ( Fig. 1, Box 1). The plant has been reported to stop bleeding particularly in the case of ophidian accidents ( de Núñez and Johnson, 1943, Braga, 1960, D’Angelo et al., 1997, Sánchez et al., 2011 and Ortega-Galvan, 2014). Reports of the topical application of the plant to alleviate itching and scratching from insect bites including ants (Elisabetsky and Gely, 1987) has been recurrently reported (Box 1), and it remains to be determined if this property is due solely to the analgesic effect. In addition P. marginatum displays antimicrobial properties with recorded applications in Brazil ( Corrêa and Pena, 1984 and D’Angelo et al., 1997), Colombia (Duke and Vasquez, 1994), Cuba (Sánchez et al., 2011) and Puerto Rico (de Núñez and Johnson, 1943). The species is also employed to treat female disorders, skin problems and insect bites ( van Andel et al., 2008, Lans and Georges, 2011 and Pereira et al., 2011).
In Suriname, Trinidad and Puerto Rico, the plant is widely used to
treat female disorders such as to clean female sexual organs, to help
parturition, and to reduce the menstruation flow, respectively ( Morton, 1977, van Andel et al., 2008 and Lans and Georges, 2011). In the French Guiana, P. marginatum is used to treat cutaneous eruptions and skin rashes ( Foungbe et al., 1976, Morton, 1977 and D’Angelo et al., 1997), and in Brazil it is used to alleviate hitching caused by insect bites (Pereira et al., 2011).
Phytochemistry
The species P. marginatum shows a distinct phytochemistry with the presence of specific secondary metabolites, not found in other Piper species. For instance, P. marginatum is the only Piper
species containing anethole, estragole, isoeugenol methyl ether, the
phenylalkanoids 3-farnesyl-4-hydroxybenzoic and
3-farnesyl-4-methoxybenzoic acids and the glycosides marginatoside and
vitexin ( Parmar et al., 1997). No other Piper species have shown the presence of these chemotaxonomic markers.
According
to the essential oil (EO) components, seven chemotypes were recognized
by Andrade et al. in their comprehensive study with 22 samples of P. marginatum collected throughout the Brazilian Amazon ( Andrade et al., 2008). The existence of seven chemotypes may induce to consider the assumption of ancient character of P. marginatum,
allowing potential speciation events to occur during recent evolution.
This hypothesis may be tested in the future by molecular phylogenetic
analysis. The composition of the EO of the leaf, stem and inflorescence
from a P. marginatum species collected in near Recife, Brazil, showed that the major component was (Z)-asarone (30.4%) on the EO of the leaf, (E)-asarone (32.6%) on the EO of the stem, and patchoulol (23.4%) on the EO of the inflorescence ( Autran et al., 2009). A P. marginatum species from Costa Rica ( Vogler et al., 2006) was rich in anethole (45.9%) and anisaldehyde (22.0%), while P. marginatum collected near Guantanamo in Cuba ( Sánchez et al., 2011) showed high amounts of isosafrole (37.3%) and nothosmyrnol (22.7%). Moreover, the EO obtained from P. marginatum
collected near Acandi, Colombia, had high concentration of anethole
(46.3%) followed by estragol (28.9%), whereas the same species collected
in Turbaco, Colombia, showed an EO rich in germacrene D (36.6%) ( Jaramillo-Colorado et al., 2015). These studies suggest that there are more than seven chemotypes on the EO of P. marginatum sensu lato.
These results point out to a dramatic variation in chemical composition
for a set of related marginatum-phenotype species but it in addition it
is necessary to consider the variability associated to chronobiological
phenomena (monthly, weekly and daily variation) as hypothesized by Moraes et al. (2014).
Most of the phytochemical studies on P. marginatum have been carried out on the EO of the plant. Twenty five monoterpen(e)-oids (1–25, Box 3), and fifty seven sesquiterpen(e)-oids (26–82, Box 3) have been identified from the EO of P. marginatum
species collected in different locations, at different moments and
studied under different conditions. Thus there are reasons to explain
the variation observed on the chemical composition of the EO
differentiated in seven chemotypes ( Andrade et al., 2008). But in addition to this variability, the assembly of previously described sub-species collated under the sensu-lato name P. marginatum
may contribute to the notable chemical variation, as each subspecies
may have a different secondary metabolism. It remains to be verified if
the populations ascribed as P. marginatum are undergoing speciation events, moreover considering its widespread geographical distribution.
The sole sesquiterpenoid which has been purified using chromatographic techniques is caryophyllene oxide (40) (de Oliveira Chaves and de Oliveira Santos, 2002). Among the thirty-nine phenylalkanoids (83–122, Box 2) reported for P. marginatum,
most of them were identified by CG-MS analysis of the EO of the plant,
while some of them were isolated to purity by chromatographic techniques
(apiol (87), (E)-asarone (89), croweacin (92), 2,6-dimethoxy-3,4-methylenedioxy-1-(2-propenyl)-benzene (95), 3-farnesyl-4-hydroxybenzoic acid (99) and 3-farnesyl-4-methoxybenzoic acid (100), 2-hydroxy-3,4-methylenedioxypropiophenone (101), marginatine (106), 3,4-methylenedioxypropiophenone (108), 2-methoxy-4,5-methylenedioxypropiophenone (109), pipermargine (118) piperonal (119), 1-(1-(Z)-propenyl)-2,4,6-trimethoxybenzene (120), safrole (121), 2,4,5-trimethoxypropiophenone (122)) ( de Diaz and Gottlieb, 1979, Maxwell and Rampersad, 1988, de Oliveira Santos et al., 1997, Santos et al., 1998, de Oliveira Santos and de Oliveira Chaves, 1999b and de Oliveira Chaves and de Oliveira Santos, 2002).
- Box 2. Reported phytochemicals identified in Piper marginatum.
The alkaloids or amides so far identified from P. marginatum are the aristolactams cepharanone B (123) and piperolactam A (124), (E,E)-N-isobutyl-2,4-octadienamide (125) and cinnamoyl pirrolidide (126) ( de Oliveira Santos and de Oliveira Chaves, 1999a, de Oliveira Chaves et al., 2003 and de Oliveira Chaves et al., 2006). Two flavanones 5,4′-dihydroxy-7-methoxyflavanone (127) and 5,7-dihydroxy-4′-methoxyflavanone (128), and two flavonoid glycosides marginatoside (129) and vitexin (130) have been isolated from the leaves of P. marginatum ( Tillequin et al., 1978 and Reigada et al., 2007). The catecholamine noradrenaline (131) was identified by high performance liquid chromatography (D’Angelo et al., 1997), and the fatty acid stearic acid (132) has been purified from the leaves (de Diaz and Gottlieb, 1979).
Biological and pharmacological applications
The sweetening effect of the plant recorded in the traditional application was attributed to the presence of (E)-anethole (83), a sweet phenylpropanoid and major compound in certain chemotypes of the EO of P. marginatum but also present in fennel (Foeniculum vulgare), star anise (Illicium verum), cicely (Myrrhis odorata) and anise root (Osmorhiza longistylis) ( Hussain et al., 1990). (E)-Anethole has been reported to provide protection against chemically-induced apoptosis and genotoxicity ( Abraham, 2001 and Galicka et al., 2014), and to be non-carcinogenic in mice (Miller et al., 1983) posing no risk to human health (Newberne et al., 1999).
Most studies evaluating the biological and pharmacological properties of P. marginatum have focused on the essential oil ( Box 3). The leaf EO demonstrated growth inhibition of Escherichia coli
bacteria with a minimum inhibitory concentration (MIC) value between
700 and 900 μg/ml against two pathogenic strains STEC0157 and EPEC0312
respectively (Duarte et al., 2007). A much lower MIC value of 120 μg/ml was found against the phytopathogenic bacterium Xanthomonas albilineans ( Sánchez et al., 2012). The leaf EO was also screened for fungal inhibition against both Alternaria solanii and Fusarium oxysporum, displaying moderate activity in disk diffusion assays ( dos Santos et al., 2011 and Duarte et al., 2013). However another study reported that the EO from P. marginatum was inactive against F. oxysporum with an MIC value higher than 500 μg/ml, while it was found to be slightly more active against Trichophyton rubrum and Trichophyton mentagrophytes with respective MIC values of 500 and 250 μg/ml (Tangarife-Castaño et al., 2014). Moreover both the EO and the ethanolic extract of P. marginatum were reported to be inactive against Candida albicans with MIC values higher than 2.0 mg/ml (Duarte et al., 2005). The EO obtained from the leaf, steam and flower of P. marginatum were tested for activity against Aedes aegypti, and found to be potent larvicidal mixtures (LC50 ranging from 19.9 to 23.8 μg/ml) with the EO from stem and flower being slightly more active than the EO from the leaf (Autran et al., 2009). A lower LC50 value of 8.3 μg/ml was reported for a leaf EO obtained from Paraiba, Brazil (Costa et al., 2010) whereas a LC50 value of 34 μg/ml was found for a leaf EO from a plant collected in the Rondonia state in Brazil (Santana et al., 2015). Moreover in the presence of the EO at 100 μg/ml, the gravid A. aegypti females reduced the number of eggs laid by one-third compared to the negative control ( Autran et al., 2009). The effect of the P. marginatum EO on brine shrimp (Artemia franciscana) lethality and Vero cells cytotoxicity was found to be comparable in the concentration-response with a LC50 value of 22.4 μg/ml against the A. franciscana nauplii after 24 h of exposition (Olivero-Verbel et al., 2009), and an IC50 value of 30.3 μg/ml against the Vero cells (Tangarife-Castaño et al., 2014). In addition the EO also demonstrated antiparasitic and insecticidal properties, with 90% of the population of Schistosoma mansoni being inhibited with 5 mg of the EO (Frischkorn et al., 1978), and 90% of the population of the fire ant Solenopsis saevissima being inhibited with a concentration of 427–480 μg/ml (Souto et al., 2012). The EO of P. marginatum showed significant antioxidant activity with a DPPH IC50 value between 1.2 and 1.5 μg/ml while the control ascorbic acid showed a DPPH IC50 value of 1.0 μg/ml (Jaramillo-Colorado et al., 2015). Furthermore the EO demonstrated repellent activity of the red flour beetle Tribolium castaneum from a concentration of 0.01 μl/ml, and also a considerable anti-alimentary effect against the cotton moth Spodoptera littoralis, being non-phytotoxic against Latucca sativa, and thus suggesting a potential application as an natural agent to control beetles and moths in agricultural settings ( Jaramillo-Colorado et al., 2015).
- Box 3. Biological and pharmacological activities of Piper marginatum.
Extract or compound Biological activity Assay Potency References Leaf EO Antibacterial In vitro against two pathogenic strains of Escherichia coli MIC (STEC0157) = 700 μg/ml
MIC (EPEC0312) = 900 μg/mlDuarte et al. (2007) In vitro against Xanthomonas albilineans MIC = 120 μg/ml Sánchez et al. (2012) Antifungal In vitro against Fusarium oxysporum Inhibition diameter = 22.5 mm, Control diameter = 69.9 mm dos Santos et al. (2011) In vitro against Alternaria solanii Inhibition % = 57 with 10 μl of EO Duarte et al. (2013) Larvicidal In vitro against Aedes aegypti larvae LC50 = 8.3 μg/ml
Control temefos LC50 = 0.3 μg/mlCosta et al. (2010) LC50 = 34 μg/ml
LC90 = 85 μg/mlSantana et al. (2015) EO Antifungal In vitro against Candida albicans MIC > 2.0 mg/ml Duarte et al. (2005) Antifungal and cytotoxicity In vitro activity against Fusarium oxysporum, Trichophyton rubrum and Trichophyton mentagrophytes and cytotoxicity against Vero cell line F. oxysporum MIC > 500 μg/ml
T. rubrum MIC = 500 μg/ml
T. mentagrophytes MIC = 250 μg/ml.
IC50 = 30.3 μg/ml against Vero cell lineTangarife-Castaño et al. (2014) Antioxidant, repellent, anti-alimentary and phytotoxic In vitro DPPH antioxidant, Tribolium castaneum repellent, Spodoptera littoralis, antialimentary, and Latucca sativa and Lolium perenne phytotoxicity activities DPPH inhibition with IC50 = 1.2–1.5 μg/ml, while the control ascorbic acid showed IC50 = 1.0 μg/ml.
EO repellent of >50% T. castaneum from 0.01 μl/ml
EO anti-alimentary to S. littoralis with 64–80% effect with 100 μg/cm2
EO (at unknown concentration) inhibited root growth of L. perenne by 54–62%, but increased root growth of L. sativa by 119–170%Jaramillo-Colorado et al. (2015) Brine shrimp lethality In vitro against Artemia franciscana cysts LC50 = 22.38 μg/ml (at 24 h)
LC50 = 12.64 μg/ml (at 48 h)Olivero-Verbel et al. (2009) Cercaricidal In vitro against Schistosoma mansoni At 10 mg, 96% of cercariae died
At 5 mg, 90% of cercariae died
At 1 mg, 24% of cercariae diedFrischkorn et al. (1978) Larvicidal In vitro against Aedes aegypti larvae Leaf EO LC50 = 23.8 μg/ml
Stem EO LC50 = 19.9 μg/ml
Flower EO LC50 = 19.9 μg/mlAutran et al. (2009) Insecticidal In vitro against the workers of the fire ant Solenopsis saevissima (Smith) LC50 = 122–167 μg/ml
LC90 = 427–480 μg/mlSouto et al. (2012) Oviposition In vitro on gravid Aedes aegypti females and counting the number of eggs laid % eggs laid (leaf) = 33%
% eggs laid (stem) = 32%
% eggs laid (flower) = 35%
At 100 μg/ml with respect to the negative controlAutran et al. (2009) Ethanolic extract Cytotoxicity In vitro against murine melanoma B16/BL6, human colon carcinoma HT-29, human lung carcinoma A549, human cervical carcinoma HeLa, and human pancreatic carcinoma PANC-1 Leaf:
B16/BL6 GI50 > 300 μg/ml
HT-29 GI50 = 55 μg/ml
A549 GI50 > 300 μg/ml
HeLa GI50 > 300 μg/ml
PANC-1 GI50 > 300 μg/ml
Root:
B16/BL6 GI50 > 300 μg/ml
HT-29 GI50 = 298 μg/ml
A549 GI50 = 240 μg/ml
HeLa GI50 > 300 μg/ml
PANC-1 GI50 = 65 μg/mlVillasmil et al. (2006) Antitumoral In vivo murine tumor induction assay The leaf extract (and not the root extract) of P. marginatum showed antitumoral activity Villasmil et al. (2006) Methanolic extract Antifungal In vitro against Colletotrichum scovillei The percentage of inhibition of mycelial growth (PIC) was 50% with a concentration of 750 μg/ml, and reached 70% at 1.5 mg/ml Araújo et al. (2014) Hydro-alcoholic extract Anti-leishmanial In vitro against Leishmania infantum amastigotes IC50 = 25 μg/ml
The positive control pentamidine showed IC50 = 2.43 μg/mlIwanaga et al. (2014) Water extract Toxicity In vivo on Wistar adult rat and albino mice LD100 = 1 g/kg (intraperitoneal)
LD > 2 g/kg (orally)D’Angelo et al. (1997) Blood pressure In vivo on rat Dose-dependent hypertension was observed with intravenous and oral administrations D’Angelo et al. (1997) Vas deferens contractility In vivo on rat Dose-dependent contractions with EC = 38.02 μg/ml D’Angelo et al. (1997) Atria contractility In vivo on guinea pig Dose-dependent contractions with doses between 2.5 and 10 μg/ml D’Angelo et al. (1997) Perfused mesenteric bed pressure In vivo on rat Dose-dependent increase of the perfusion pressure of mesenteric arteria with EC = 159.6 μg D’Angelo et al. (1997) Analgesia In vivo on mice A reduction of twist movements was observed in treated animals with 0.5 and 1.0 mg/kg oral doses D’Angelo et al. (1997) Anti-inflammatory of paw edema In vivo on rat Dose-dependent reduction of swelling with 0.5 and 1.0 mg/kg oral doses D’Angelo et al. (1997) Pleural leukocyte count In vivo on rat No effect on exudate volume and leukocyte count with 0.5 and 1.0 mg/kg oral doses D’Angelo et al. (1997) Purified flavonoids Antifungal In vitro autobiography against Cladosporus cladosporioides and Cladosporus sphaerospernum Amount required to inhibit both C. cladosporioides and C. sphaerospernum:
(107) – 10.0 μg
(108) – 5.0 μg
(109) – 5.0 μg
(127) – 1.0 μg
(128) – 1.0 μgReigada et al. (2007)
Both leaf and root from P. marginatum
collected in Yutaje, Venezuela were extracted with ethanol and the
ethanolic extracts were tested for cytotoxicity against a collection of
cancer cell lines ( Villasmil et al., 2006). The leaf extract was active against the human colon carcinoma line HT-29 with a GI50
of 55 μg/ml but inactive against the other cancer lines, whereas the
root extract was found active against the human pancreatic carcinoma
PANC-1 (GI50 65 μg/ml), and moderately active against colon HT-29 (GI50 298 μg/ml) and lung A549 (GI50 240 μg/ml) carcinoma cell lines (Villasmil et al., 2006). A murine in vivo
experiment was performed and the leaf extract showed a marked
antitumoral effect decreasing by half the size of the tumors compared to
the negative control. Interestingly the root extract was inactive
suggesting that potential antitumoral compounds are present in the leaf
but absent in the root, and thus these compounds could be easily
differentiated by HPLC analysis of the extracts. The methanolic extract
obtained from P. marginatum leaf collected in Pernambuco, Brazil, was examined for antifungal activity against the phytopathogenic fungi Colletotrichum scovillei, which causes anthracnose on bell peppers ( Araújo et al., 2014).
The methanolic extract displayed a dose-dependent inhibition of
mycelial growth, achieving 50% inhibition with a concentration of
750 μg/ml. Although the methanolic extract was fractioned by column
chromatography and a significantly active fraction was separated, the
active antifungal compounds remains to be identified. Moreover the
hydroalcoholic extract was screened for activity against Leishmania infantum amastigotes and showed an IC50 value of 25 μg/ml, while the positive control pentamidine showed an IC50 value of 2.43 μg/ml (Iwanaga et al., 2014).
P. marginatum
has recurrently being employed in the traditional medicine as water
decoction or infusion, and therefore D’Angelo and collaborators focused
on the evaluation of in vivo pharmacological properties of the water extract ( D’Angelo et al., 1997).
There were no toxic effects observed on Wistar rats or albino mice when
the water extract was administered orally up to 2 g/kg. However when
administered intraperitoneally, a dose higher than 0.1 g/kg caused
piloerection, quietness, lacrimation, muscle relaxation and dyspnea. At a
intraperitoneal dose of 1.0 g/kg all animals died within 15 min (D’Angelo et al., 1997).
The water extract also had a significant effect on blood pressure. The
mean blood pressure of the control rats was 95.5 mmHg, while the
intravenous administration of 0.1–0.5 mg/kg doses of P. marginatum water extract, clearly induced a dose-dependent increase to values ranging from 121.1 to 141.5 mmHg (D’Angelo et al., 1997).
The hypertensive effect was also observed after oral administration of
the water extract at 1 mg/kg. A dose-dependent increase of the rat
mesenteric arterial pressure was also detected. In addition both in the
vas deferens duct of the rat and the atria in the heart of the guinea
pig, the frequency of contractions increased in a dose-dependent manner
with the administration of the water extract. The water extract when
administered orally at 0.5 and 1.0 mg/kg displayed analgesia in the
writhing test in mice and a significant reduction on the edema
(inflammation) of the rat paw induced by carrageenan. There was no
effect of the P. marginatum water extract on leukocyte counts
in the pleurisy induced by carrageenin, suggesting that the
anti-inflammatory effect is related to a vasoconstriction action of the
water extract of P. marginatum, and not a specific anti-inflammatory action ( D’Angelo et al., 1997).
Among all the identified secondary metabolites present in P. marginatum,
only five have been tested for a biological activity and these are
three arylpropanoids 1-(3,4-methylenedioxyphenyl)-propan-1-ol
(marginatumol, 107), 3,4-methylenedioxypropiophenone (108), 2-methoxy-4,5-methylenedioxypropiophenone (109), and the two flavanones 5,4′-dihydroxy-7-methoxyflavanone (127) and 5,7-dihydroxy-4′-methoxyflavanone (128). A bioautographic method was employed to evaluate their antifungal effect against Cladosporus cladosporioides and Cladosporus sphaerospernum and the most active compounds were the two flavanones (127) and (128), which inhibited both microorganisms with an amount as little as 1 μg (Reigada et al., 2007). The two propiophenones (108) and (109) inhibited the growth of the fungi with 5 μg, whereas the alcohol marginatumol, (107) required 10 μg to inhibit the fungi.
Conclusion
The species P. marginatum,
widely used in the traditional medicine of the Caribbean region,
primarily to treat gastrointestinal problems but also employed as
analgesic, hemostatic and to cure insect bites, contains a variable
mixture of terpenoids, phenylalkanoids, amides and flavonoids. Some of
these compounds, including anethole, estragole, isoeugenol methyl ether,
3-farnesyl-4-hydroxybenzoic and 3-farnesyl-4-methoxybenzoic acids,
marginatoside and vitexin, are not present in other Piper species, and are thus chemotaxonomic markers for P. marginatum. The high variability of chemotypes observed within P. marginatum sensu lato
may reflect upon speciation events, or other factors which remains to
be fully investigated. The distinctiveness of the chemical composition
translate into a range of biological and pharmacological applications,
which according to the reported potency, the larvicidal effect against A. aegypti,
the antifungal activity against phytopathogenic fungi and the
hemostatic and antitumoral potential, are worth highlighting for future
research.
Ethical disclosures
Protection of human and animal subjects
The
authors declare that the procedures followed were in accordance with
the regulations of the relevant clinical research ethics committee and
with those of the Code of Ethics of the World Medical Association
(Declaration of Helsinki).
Confidentiality of data
The authors declare that they have followed the protocols of their work center on the publication of patient data.
Right to privacy and informed consent
The
authors have obtained the written informed consent of the patients or
subjects mentioned in the article. The corresponding author is in
possession of this document.
Authors’ contributions
JB
and JDG searched the literature. JB collected data in tables. JDG
organized the information, prepared the figures and wrote the paper.
Conflicts of interest
The authors have no conflicts of interest to declare.
Acknowledgments
The authors acknowledge financial support from the Universidad del Norte
(Agenda Interna 2014-0014) for the project “Búsqueda de nuevos agentes
anti-tuberculosis en inflorescencias de Piper del Caribe Colombiano”.
The authors are grateful to Dr. Maria Cristina Martinez-Habibe
(Uninorte) for useful discussions.
References
- Abraham, 2001
- Anti-genotoxicity of trans-anethole and eugenol in mice
- Food Chem. Toxicol., 39 (2001), pp. 493–498
- | | |
- Andrade et al., 2008
- Variability in essential-oil composition of Piper marginatum sensu lato
- Chem. Biodivers., 5 (2008), pp. 197–208
- | |
- Araújo et al., 2014
- Extracts of Piper marginatum and Azadirachta indica for the control of Colletotrichum scovillei in bell pepper
- Pesq. Agrop. Bras., 49 (2014), pp. 88–94
- | |
- Autran et al., 2009
- Chemical composition, oviposition deterrent and larvicidal activities against Aedes aegypti of essential oils from Piper marginatum Jacq. (Piperaceae)
- Bioresour. Technol., 100 (2009), pp. 2284–2288
- | | |
- Bernal et al., 2011
- Pautas para el conocimiento, conservación y uso sostenible de las plantas medicinales nativas en Colombia: Estrategia nacional para la conservación de plantas, Bogotá, Colombia
- (2011), p. 167
- Braga, 1960
- Plantas do Nordeste, especialmente do Ceará
- Imprensa Oficial, Fortaleza, Brasil (1960) 540 pp.
- Branch and Silva, 1983
- Folk medicine of Alter do Chão, Pará, Brazil
- Acta Amazon., 13 (1983), pp. 737–797
- |
- Callejas, 1986
- Taxonomic revision of Piper subgenus Ottonia (Piperaceae)
- (Ph.D. thesis) City University of New York, New York (1986) 150 pp.
- Candolle, 1902
- Piperaceae. vol 3. Lipsiae, Borntraeger
- Geneva Botanical Garden (1902) 124 pp.
- Corrêa and Pena, 1984
- Dicionário das plantas úteis do Brasil e das exóticas cultivadas
- Ministério da Agricultura, Instituto Brasileiro de Desenvolvimento Florestal, Rio de Janeiro (1984) 747 pp.
- Costa et al., 2010
- Composição química e toxicidade de óleos essenciais de espécies de Piper frente a larvas de Aedes aegypti L. (Diptera: Culicidae)
- Lat. Am. J. Pharm., 29 (2010), pp. 463–467
- |
- D’Angelo et al., 1997
- Pharmacology of Piper marginatum Jacq. a folk medicinal plant used as an analgesic, antiinflammatory and hemostatic
- Phytomedicine, 4 (1997), pp. 33–40
- | | |
- de Albuquerque et al., 2007
- Medicinal and magic plants from a public market in northeastern Brazil
- J. Ethnopharmacol., 110 (2007), pp. 76–91
- | | |
- de Diaz and Gottlieb, 1979
- Propiophenones from Piper marginatum
- Planta Med., 35 (1979), pp. 190–191
- |
- de Núñez and Johnson, 1943
- A preliminary study of Piper marginatum Jacq.
- J. Am. Pharm. Assoc., 32 (1943), pp. 234–236
- | | |
- de Oliveira Chaves et al., 2003
- 1-Cinnamoyl pyrrolidide from Piper marginatum
- Biochem. Syst. Ecol., 31 (2003), pp. 1213–1214
- | | |
- de Oliveira Chaves et al., 2006
- Aristolactams from Piper marginatum Jacq. (Piperaceae)
- Biochem. Syst. Ecol., 34 (2006), pp. 75–77
- | | |
- de Oliveira Chaves and de Oliveira Santos, 2002
- Constituents from Piper marginatum fruits
- Fitoterapia, 73 (2002), pp. 547–549
- | | |
- de Oliveira Santos and de Oliveira Chaves, 1999a
- (E,E)-N-Isobutyl-2,4-octadienamide from Piper marginatum
- Biochem. Syst. Ecol., 27 (1999), pp. 113–114
- de Oliveira Santos et al., 1997
- Croweacin from Piper marginatum
- Biochem. Syst. Ecol., 25 (1997), pp. 471–472
- | | |
- de Oliveira Santos and de Oliveira Chaves, 1999b
- 2,4,5-Trimethoxypropiophenone from Piper marginatum
- Biochem. Syst. Ecol., 27 (1999), pp. 539–541
- |
- Di Stasi and Hiruma-Lima, 2002
- Plantas medicinais na Amazônia e na Mata Atlântica
- Editor UNESP, São Paulo (2002), pp. 125–126
- dos Santos et al., 2011
- Atividade fungicida do óleo essencial de Piper marginatum L. (Piperaceae) sobre Fusarium oxysporum (Schlecht) in vitro. Saude Pesq. 4
- (2011)
- Duarte et al., 2005
- Anti-Candida activity of Brazilian medicinal plants
- J. Ethnopharmacol., 97 (2005), pp. 305–311
- | | |
- Duarte et al., 2007
- Activity of essential oils from Brazilian medicinal plants on Escherichia coli
- J. Ethnopharmacol., 111 (2007), pp. 197–201
- | | |
- Duarte et al., 2013
- Efecto in vitro de aceites esenciales sobre Alternaria solani Sorauer
- Rev. Protec. Veg., 28 (2013), pp. 54–59
- Duke and Vasquez, 1994
- Amazonian Ethnobotanical Dictionary
- Taylor & Francis, CRC Press, Boca Raton (1994), pp. 138–139
- Elisabetsky and Gely, 1987
- Plantes médicinales utilisées en Amazonie comme fond potentiel de nouveaux agents thérapeutiques dans les cas d’allergie, thrombose et inflammation
- J. Agric. Tradit. Bot. Appl., 34 (1987), pp. 143–151
- | |
- Foungbe et al., 1976
- Sur une pipéracée de Guyane, le Piper marginatum Jacq.
- Ann. Pharm. Fr., 34 (1976), pp. 339–343
- |
- Frischkorn et al., 1978
- Cercaricidal activity of some essential oils of plants from Brazil
- Naturwissenschaften, 65 (1978), pp. 480–483
- | |
- Galicka et al., 2014
- Anethole prevents hydrogen peroxide-induced apoptosis and collagen metabolism alterations in human skin fibroblasts
- Mol. Cell. Biochem., 394 (2014), pp. 217–224
- |
- García, 1974
- Flora medicinal de Colombia: botánica médica
- (Segunda edición ed.)Tercer Mundo Editores (1974)
- Giraldo Tafur, 1996
- Medicina tradicional de las mujeres Siona del resguardo de Buenavista en el río Putumayo
- Caldasia, 18 (1996), pp. 227–238
- |
- Hazlett, 1986
- Ethnobotanical observations from cabecar and guaymí settlements in Central America
- Econ. Bot., 40 (1986), pp. 339–352
- | |
- Hussain et al., 1990
- Sweetening agents of plant origin: phenylpropanoid constituents of seven sweet-tasting plants
- Econ. Bot., 44 (1990), pp. 174–182
- | |
- Iwanaga et al., 2014
- Antileishmnaial evaluation activity of crude hydroalcoholic extract of Piper marginatum Jacq.
- VI Simpósio Internacional de Pós-Graduacao e Pesquisa, Sao Paulo, Brasil (2014), p. 9
- Jacquin, 1786
- Icones plantarum rariorum. Lugduni Batavorum, Argentorati Wappler, White et filium, Luchtmans and König, London
- (1786), p. 2
- Jaramillo-Colorado et al., 2015
- Estudio comparativo de la composición volátil y las actividades biológicas del aceite esencial de Piper marginatum Jacq. Colombiano
- Bol. Latinoam. Caribe, 14 (2015), pp. 343–354
- Jaramillo et al., 2008
- A phylogeny of the tropical genus Piper using ITS and the chloroplast intron psbJ-petA
- Syst. Bot., 33 (2008), pp. 647–660
- | |
- Johnson, 1998
- CRC Ethnobotany Desk Reference
- Taylor & Francis, CRC Press, Boca Raton (1998), p. 631
- Lans and Georges, 2011
- Women's knowledge of herbs used in reproduction in Trinidad and Tobago
- M. Rai, D. Acharya, J.L. Rios (Eds.), Ethnomedicinal Plants: Revitalizing of Traditional Knowledge of Herbs, CRC Press (2011), pp. 115–134
- Maxwell and Rampersad, 1988
- Prenylated 4-hydroxybenzoic acid derivatives from Piper marginatum
- J. Nat. Prod., 51 (1988), pp. 370–373
- | |
- Miller et al., 1983
- Structure-activity studies of the carcinogenicities in the mouse and rat of some naturally occurring and synthetic alkenylbenzene derivatives related to safrole and estragole
- Cancer Res., 43 (1983), pp. 1124–1134
- |
- Moraes et al., 2014
- Circadian variation of essential oil from Piper marginatum Jacq.
- Bol. Latinoam. Caribe, 13 (2014), pp. 270–277
- |
- Morton, 1977
- Some folk-medicine plants of central American markets
- Pharm. Biol., 15 (1977), pp. 165–192
- | |
- Newberne et al., 1999
- The FEMA GRAS Assessment of trans-anethole used as a flavouring substance
- Food Chem. Toxicol., 37 (1999), pp. 789–811
- | | |
- Oliveira Santos and Oliveira Chaves, 2000
- Assignments of 1H and 13C resonante signals in 2-methoxy-4,5-methylenedioxypropiophenone with the assistance of 1D and 2D NMR experiments
- Acta Farm. Bonaer., 19 (2000), pp. 45–48
- Olivero-Verbel et al., 2009
- Acute toxicity against Artemia franciscana of essential oils isolated from plants of the genus Lippia and Piper collected in Colombia
- Bol. Latinoam. Caribe, 8 (2009), pp. 419–427
- |
- Ortega-Galvan, 2014
- Mi familia usa Piper marginatum para curar la mordedura de serpiente, Megua, Baranoa, Atlántico, Colombia
- (2014) (Personal communication)
- Parmar et al., 1997
- Phytochemistry of the genus Piper
- Phytochemistry, 46 (1997), pp. 597–673
- | | |
- Pereira et al., 2011
- Caracterización y uso de pimientas en una comunidad Quilombola de la Amazonía Oriental (Brasil)
- J. Bot. Res. Inst. Texas, 5 (2011), pp. 255–272
- |
- Ramos et al., 1986
- Essential oil of Piper marginatum
- J. Nat. Prod., 49 (1986), pp. 712–713
- | |
- Reigada et al., 2007
- Chemical constituents from Piper marginatum Jacq. (Piperaceae) – antifungal activities and kinetic resolution of (RS)-marginatumol by Candida antarctica lipase (Novozym 435)
- Tetrahedron-Asymmetry, 18 (2007), pp. 1054–1058
- | | |
- Rodrigues and Andrade, 2014
- Levantamento etnobotânico das plantas medicinais utilizadas pela comunidade de Inhamã, Pernambuco, Nordeste do Brasil
- Rev. Bras. Plantas Med., 16 (2014), pp. 721–730
- | |
- Sánchez et al., 2011
- Caracterización química y actividad antimicrobiana del aceite esencial de Piper marginatum Jacq.
- Rev. Protec. Veg., 26 (2011), pp. 170–176
- |
- Sánchez et al., 2012
- Efecto del aceite esencial de Piper marginatum Jacq. y sus componentes sobre Xanthomonas albilineans (Ashby) Dawson
- Rev. Protec. Veg., 27 (2012), pp. 39–44
- |
- Santana et al., 2015
- Essential oils of leaves of Piper species display larvicidal activity against the dengue vector, Aedes aegypti (Diptera: Culicidae)
- Rev. Bras. Plantas Med., 17 (2015), pp. 105–111
- |
- Santos et al., 1998
- Phenylalkanoids from Piper marginatum
- Phytochemistry, 49 (1998), pp. 1381–1384
- | | |
- Sequeda-Castañeda et al., 2015
- Piper marginatum Jacq. (Piperaceae): phytochemical: therapeutic, botanical insecticidal and phytosanitary uses
- Pharmacol. Online, 3 (2015), pp. 136–145
- Souto et al., 2012
- Insecticidal activity of Piper essential oils from the Amazon against the fire ant Solenopsis saevissima (Smith) (Hymenoptera: Formicidae)
- Neotrop. Entomol., 41 (2012), pp. 510–517
- | |
- Surana et al., 2006
- Non-saccharide natural intense sweeteners. An overview of current status
- Nat. Prod. Rad., 5 (2006), pp. 270–278
- |
- Tangarife-Castaño et al., 2014
- Anti-dermatophyte, anti-Fusarium and cytotoxic activity of essential oils and plant extracts of Piper genus
- J. Essent. Oil Res., 26 (2014), pp. 221–227
- | |
- Tillequin et al., 1978
- Flavonoides de Piper marginatum
- Planta Med., 33 (1978), pp. 46–52
- | |
- Trelease and Yuncker, 1950
- The Piperaceae of Northern South America, vol. 1, University of Illinois Press, Urbana (1950), pp. 73–78
- Tropicos.org, 2015
- !Piper marginatum Jacq.
- Missouri Botanical Garden (2015) http://www.tropicos.org/Name/25001136 (visited 10.09.15)
- van Andel et al., 2008
- Dry sex in Suriname
- J. Ethnopharmacol., 116 (2008), pp. 84–88
- | | |
- van den Berg, 1982
- Plantas medicinais na Amazônia: contribuição ao seu conhecimento sistemático
- Conselho Nacional de Desenvolvimento Científico e Tecnológico, Programa Trópico Umido/Museo Paraense Emílio Goeldi, Belém (1982) 223 pp.
- Vigneron et al., 2005
- Antimalarial remedies in French Guiana: a knowledge attitudes and practices study
- J. Ethnopharmacol., 98 (2005), pp. 351–360
- | | |
- Villasmil et al., 2006
- Cytotoxic and antitumor activities of Venezuelan plant extracts in vitro and in vivo
- Pharmacol. Online, 3 (2006), pp. 808–816
- Vogler et al., 2006
- Chemical constituents of the essential oils of three Piper species from Monteverde, Costa Rica
- J. Essent. Oil Bear. Plants, 9 (2006), pp. 230–238
- | |
- Yukes and Balick, 2011
- Dominican Medicinal Plants: A Guide for Health Care Providers
- (2nd ed.)The New York Botanical Garden, New York (2011), p. 25
© 2016 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editora Ltda.